Mr. Moyes has 30 years of management and leadership experience. He was instrumental in the financial development and expansion of Myriad Genetics and currently sits on the board for Osiris Therapeutics, Bicardia, Integrated Diagnostics and Puma Biotechnology.
More Articles on Orthopedic Devices:
Globus Medical 3Q Worldwide Sales Reach $94.8M, Up 12.5%
X-spine Announces FDA Approval for 2 Spine Systems
Zimmer Pulls Metal-on-Metal Hip Device From Australia
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
